An overview of non-Hodgkin’s lymphoma
CPD Previous     Next

An overview of non-Hodgkin’s lymphoma

Helen King Education and practice development nurse, Trinity Hospice, Clapham, London
Rebecca Myatt Nurse case manager, Thoracic surgery, Guy’s Hospital, London

Non-Hodgkin’s lymphoma is a heterogeneous group of lymphoproliferative malignancies with differing patterns of behaviour and responses to treatment. Chemotherapy, radiotherapy and stem cell transplantation are the main treatment modalities, but targeted therapies such as monoclonal antibodies are improving survival. The complex nature of the disease, and different treatment pathways, mean that nurses working in this area need in-depth knowledge to provide patient education, continuity of care and advice on current treatment options, as well as to ensure an optimal patient journey.

Cancer Nursing Practice. 13, 1, 31-38. doi: 10.7748/cnp2014.02.13.1.31.e1042

Correspondence

hking@trinityhospice.com

Peer review

This article has been subject to double blind peer review

Conflict of interest

None declared

Received: 21 October 2013

Accepted: 24 December 2013

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or